Cannon Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Cannon Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,750	Closed	-$2.9K	–	113
2026 Q1	$2.9K	Hold	11,750	–	–	﹤0.01%	87
2025 Q4	$5.09K	Buy	+11,750	New	+$6.23K	﹤0.01%	83

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Cannon Advisors's SGMO Position: Q2 2026 in Review

Cannon Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 11,750 shares — an estimated $2.9K sold.

Cannon Advisors first reported a position in SGMO in Q4 2025 and held it in 2 quarters. The position peaked at $5.09K in Q4 2025. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Cannon Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Cannon Advisors sold 11,750 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $2.9K.
Cannon Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2025 and held it in 2 quarters.
Cannon Advisors's SANGAMO THERAPEUTICS INC position peaked at $5.09K in Q4 2025.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Cannon Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.